Developer docs
API playgroundTry for free, no card

Search company profiles

CDX Analytics

Full company profile

uuid0038tz3

Namestring
CDX Analytics
Company typeenum
Private
Founded yearint
2015
Short descriptiontext

CDX Analytics is a private U.S. medical and analytical testing laboratory founded in 2015 in Salem, serving clients in the healthcare and life sciences sector with laboratory-based diagnostic and analytical services using a workforce of 11-50 employees.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSalem, United States
HQ citystring
Salem
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
analytical testing services, medical laboratory testing, diagnostic testing lab, chemical analysis services, specimen testing laboratory
Industry5 codes
PRIMARYHLAHAAAJ
Companion Diagnostics (CDx) & Precision Medicine IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAEAJ
Companion Diagnostics (CDx) Development & Trial Testing Support
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAF
Companion Diagnostics (CDx) & Therapy Selection Assays
SECONDARYHLAAANAC
Companion Diagnostics (CDx) Development & Commercialization
SECONDARYHLAAAMAB
Companion Diagnostic (CDx) Co-Development Services (biopharma partnerships, clinical strategy)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Medical and Analytical Testing Laboratory Services
Social media profiles1 record
Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CDX Analytics operates as a medical and analytical testing laboratory based in Salem, United States. The company provides medical and analytical testing services to external clients, operating as a private for-profit laboratory founded in 2015 with a staff of 11-50 employees.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Medical and Analytical Testing Services
No data
Peers10 records
TypeBroad incumbent
Description

Agilent acquired Resolution Bioscience to expand its CDx and liquid biopsy capabilities. Comparable as a CDx development partner serving biopharma, now backed by a large life sciences tools incumbent.

TypeBroad incumbent
Description

Labcorp is a global clinical laboratory network offering diagnostic testing and CDx development services through its diagnostics and drug development segments. Comparable as a medical/analytical testing laboratory with biopharma CDx capabilities, scaled across thousands of tests.

TypeEmerging player
Description

Personalis offers ImmunoID next-generation sequencing and has a CDx partnership with Natera-related and pharma oncology programs. Comparable as a smaller molecular diagnostics firm pursuing biopharma CDx engagements.

TypeDirect peer
Description

Guardant Health specializes in liquid biopsy and CDx development, with multiple FDA-approved companion diagnostics. Comparable as a precision diagnostics company with both clinical testing and biopharma CDx co-development revenue streams.

5Tempus AI
TypeDirect peer
Description

Tempus provides genomic sequencing and CDx services alongside its broader AI-driven precision medicine platform. Comparable as a precision diagnostics lab with biopharma data and CDx offerings.

TypeBroad incumbent
Description

Quest Diagnostics is a large reference laboratory offering advanced diagnostics, including oncology and molecular testing. Comparable as a medical/analytical testing laboratory serving physicians, hospitals, and biopharma, though operating at vastly greater scale.

TypeBroad incumbent
Description

Foundation Medicine is a leader in comprehensive genomic profiling and CDx development, now part of Roche. It serves as the dominant scaled CDx partner for biopharma and represents the primary incumbent CDX Analytics would compete against for major pharma programs.

TypeDirect peer
Description

NeoGenomics operates a specialty oncology and CDx testing laboratory serving hospitals, physicians, and biopharma, with a dedicated CDx division. Directly comparable as a clinical and pharma-focused molecular/companion diagnostics lab.

TypeDirect peer
Description

Caris provides molecular profiling and CDx services to biopharma, with a focus on ADAPT trials and therapy selection. Directly comparable as a precision oncology diagnostics lab offering biopharma partnership models.

TypeDirect peer
Description

PGDx, acquired by Labcorp, develops regulated IVD and CDx kits for next-generation sequencing. Comparable as a molecular diagnostics firm building CDx partnerships with biopharma sponsors.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CDX Analytics

Medical and Analytical Testing Laboratory Servicescdxanalytics.com

CDX Analytics is a private U.S. medical and analytical testing laboratory founded in 2015 in Salem, serving clients in the healthcare and life sciences sector with laboratory-based diagnostic and analytical services using a workforce of 11-50 employees.

CDX Analytics firmographics

Firmographics
Name
CDX Analytics
Website
https://cdxanalytics.com
Company type
Private
Founded year
2015
Headcount range
1–10 employees
Short description
CDX Analytics is a private U.S. medical and analytical testing laboratory founded in 2015 in Salem, serving clients in the healthcare and life sciences sector with laboratory-based diagnostic and analytical services using a workforce of 11-50 employees.
Ownership category
akta.pro rank

CDX Analytics industry classification

Industry
Product category
Medical and Analytical Testing Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAJ
Companion Diagnostics (CDx) & Precision Medicine IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAEAJ
Companion Diagnostics (CDx) Development & Trial Testing Support
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAF
Companion Diagnostics (CDx) & Therapy Selection Assays
SECONDARYHLAAANAC
Companion Diagnostics (CDx) Development & Commercialization
SECONDARYHLAAAMAB
Companion Diagnostic (CDx) Co-Development Services (biopharma partnerships, clinical strategy)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Analytical testing services
  • Medical laboratory testing
  • Diagnostic testing lab
  • Chemical analysis services
  • Specimen testing laboratory

Where CDX Analytics is headquartered

Location

Headquarters

HQ city
Salem
HQ country
United States
HQ region
North America

Markets served

CDX Analytics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

CDX Analytics product offering

Product offering

Core offering

CDX Analytics operates as a medical and analytical testing laboratory based in Salem, United States. The company provides medical and analytical testing services to external clients, operating as a private for-profit laboratory founded in 2015 with a staff of 11-50 employees.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical and Analytical Testing Services

Companies that use CDX Analytics

Customer profile

Ideal customer profiles1 record

CDX Analytics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CDX Analytics competitors and assessment

Company assessment

Broad incumbents

  • Resolution Bioscience (Agilent): Agilent acquired Resolution Bioscience to expand its CDx and liquid biopsy capabilities. Comparable as a CDx development partner serving biopharma, now backed by a large life sciences tools incumbent.
  • Labcorp (Laboratory Corporation of America): Labcorp is a global clinical laboratory network offering diagnostic testing and CDx development services through its diagnostics and drug development segments. Comparable as a medical/analytical testing laboratory with biopharma CDx capabilities, scaled across thousands of tests.
  • Quest Diagnostics: Quest Diagnostics is a large reference laboratory offering advanced diagnostics, including oncology and molecular testing. Comparable as a medical/analytical testing laboratory serving physicians, hospitals, and biopharma, though operating at vastly greater scale.
  • Foundation Medicine (Roche): Foundation Medicine is a leader in comprehensive genomic profiling and CDx development, now part of Roche. It serves as the dominant scaled CDx partner for biopharma and represents the primary incumbent CDX Analytics would compete against for major pharma programs.

Emerging players

  • Personalis: Personalis offers ImmunoID next-generation sequencing and has a CDx partnership with Natera-related and pharma oncology programs. Comparable as a smaller molecular diagnostics firm pursuing biopharma CDx engagements.

Direct peers

  • Guardant Health: Guardant Health specializes in liquid biopsy and CDx development, with multiple FDA-approved companion diagnostics. Comparable as a precision diagnostics company with both clinical testing and biopharma CDx co-development revenue streams.
  • Tempus AI: Tempus provides genomic sequencing and CDx services alongside its broader AI-driven precision medicine platform. Comparable as a precision diagnostics lab with biopharma data and CDx offerings.
  • NeoGenomics Laboratories: NeoGenomics operates a specialty oncology and CDx testing laboratory serving hospitals, physicians, and biopharma, with a dedicated CDx division. Directly comparable as a clinical and pharma-focused molecular/companion diagnostics lab.
  • Caris Life Sciences: Caris provides molecular profiling and CDx services to biopharma, with a focus on ADAPT trials and therapy selection. Directly comparable as a precision oncology diagnostics lab offering biopharma partnership models.
  • Personal Genome Diagnostics (PGDx / Labcorp): PGDx, acquired by Labcorp, develops regulated IVD and CDx kits for next-generation sequencing. Comparable as a molecular diagnostics firm building CDx partnerships with biopharma sponsors.

Market position

Customer concentration

CDX Analytics social profiles

Digital presence

CDX Analytics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CDX Analytics leadership team

Management profile

Number of profiles

CDX Analytics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CDX Analytics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CDX Analytics

What does CDX Analytics do?

CDX Analytics operates as a medical and analytical testing laboratory based in Salem, United States. The company provides medical and analytical testing services to external clients, operating as a private for-profit laboratory founded in 2015 with a staff of 11-50 employees.

When was CDX Analytics founded?

CDX Analytics was founded in 2015. It employs 1 to 10 people.

Where is CDX Analytics based?

CDX Analytics is headquartered in Salem, United States, in the North America region.

Who are CDX Analytics's main competitors?

Broad incumbents on record are Resolution Bioscience (Agilent), Labcorp (Laboratory Corporation of America), Quest Diagnostics and Foundation Medicine (Roche). Personalis is listed as an emerging player. Direct peers are Guardant Health, Tempus AI, NeoGenomics Laboratories, Caris Life Sciences and Personal Genome Diagnostics (PGDx / Labcorp).

Does CDX Analytics have an API?

No public API is recorded for CDX Analytics.

What industry is CDX Analytics in?

CDX Analytics's product category is Medical and Analytical Testing Laboratory Services. Its primary akta.pro industry code is HLAHAAAJ, Companion Diagnostics (CDx) & Precision Medicine IVD, with a secondary code of HLAGAEAJ, Companion Diagnostics (CDx) Development & Trial Testing Support. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireACT Laboratories, Inc. Expands into Massachusetts with the Acquisition of CDX AnalyticsACT Laboratories, Inc. has announced an agreement to acquire CDX Analytics, a cannabis testing laboratory based in Massachusetts, to expand its geographic footprint and scientific capabilities. Upon completion of the deal, which is subject to regulatory approval, ACT Labs will operate in six states including Illinois, Michigan, New York, Ohio, and Pennsylvania, with plans to enter a seventh state by early 2023.BioSpaceACT Laboratories, Inc. Expands into Massachusetts with the Acquisition of CDX AnalyticsACT Laboratories, Inc. has entered into an agreement to acquire CDX Analytics, LLC, a cannabis testing laboratory based in Massachusetts, to expand its geographic footprint and scientific capabilities. This acquisition brings ACT Labs' operational presence to six states, with plans to potentially reach seven by early 2023, subject to regulatory approval in Massachusetts. The deal aims to consolidate leadership in the legal cannabis market by leveraging standardized best practices and advanced testing technologies.GlobeNewswireLexaGene Reports on Beta Results from Cannabis-Focused Testing LaboratoryLexaGene announced that its beta unit at CDX Analytics successfully tested cannabis samples containing cannabinoids, with all PCR runs succeeding. The company's analyzer reports results in about an hour and uses 95% less hands-on time than CDX's current method. The beta trial represents another market segment for the company's open-access technology.Boston.comMassachusetts just gave final approval to 2 marijuana labs. Here’s what that means for dispensaries opening.Massachusetts gave final approval to two marijuana labs, CDX Analytics and MCR Labs, to test recreational marijuana. The labs must wait three days to coordinate opening logistics, and three retail dispensaries have final licenses but no commence operations notices. First sales are expected within a week or two.